4 ms·

So is this one of the emerging multi billion dollar companies built on the new gene editing tools?

• blaufast 6y ago
  This one looks like it makes money which is strange
  • why_only_15 6y ago
    > [the company expects] revenue to surpass $30 million this year, though the company is not yet profitable as it spends heavily to expand
  • elmolino89 6y ago
    The strangest thing is the supposed use of a human(?) cancer cell enzyme. While cancer genomes mutate a lot, I doubt that starting from some canonical human protein it is feasible to get an enzyme competitive in performance with enzymes from bacteria, fungi or algae. There are millions of species of these with bunch of weirdos living anywhere from hot springs to hipersaline marshes and surfaces of the icebergs.